Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia
ENCell
View at source ↗Clinical trial
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Brief summary
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients with Sarcopenia
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Trial details
- status
- NOT_YET_RECRUITING
- phase
- PHASE1, PHASE2
- study type
- INTERVENTIONAL
- enrollment
- 132
- sponsor
- ENCell
- conditions
- Sarcopenia
- interventions
- DRUG: EN001; DRUG: EN001; DRUG: EN001; DRUG: EN001; DRUG: EN001; DRUG: EN001 Placebo
- start date
- 2027-03-01
- start date type
- ESTIMATED
- primary completion date
- 2029-10-31
- has results
- false
- data source
- ClinicalTrials.gov
- data processed
- 2026-10-29T09:00:05
- modifications
- selected fields only; whitespace normalized; brief summary truncated to 2,000 characters
Record
- Archive ID
- nct:NCT07808905
- Published
- Sep 9, 2026
- Updated
- Sep 11, 2026
- Venue
- ClinicalTrials.gov
- ClinicalTrials.gov
- NCT07808905
- Categories
- Sarcopenia
- License
- ClinicalTrials.gov terms (attribution, processing date, modifications noted)
- Provenance
- clinicaltrials